GROVEPOINT INVESTMENT MANAGEMENT LLP
GROVEPOINT INVESTMENT MANAGEMENT LLP is a buyout, debt and other fund in APAC and GB investing in Healthcare, life-sciences, private-credit and real-estate.
- Stages
- buyout, debt, other
- Sectors
- Healthcare, life-sciences, private-credit, real-estate
- Invests in
- APAC, GB
- Actively investing
- Yes
- Founded
- 2012
- Assets under management
- $300M
- Website
- grovepoint.co.uk
Check size not disclosed
Thesis
Grovepoint Investment Management LLP, founded in 2012 and based in London, is a specialized investment firm managing segregated multi-asset portfolios with a focus on private market transactions. Their strategy involves investing across the capital structure, including buyout strategies and a geographic focus on the Asia-Pacific region, as well as the biotech and life sciences sectors. GIM generally seeks 'out of favor' assets acquired at bargain prices due to funding gaps or forced selling. As of June 2012, they managed approximately $300 million in client assets, with plans to grow to $1 billion. Specific fund AUMs as of March 31, 2026, included $1.7 million for GIM Investments PCC Limited - LS 12 US Cell and $54.6 million for GIM Investments PCC Ltd - Chemical Cell.
Common questions
Does GROVEPOINT INVESTMENT MANAGEMENT LLP invest at the buyout stage?
Yes. GROVEPOINT INVESTMENT MANAGEMENT LLP lists buyout, debt and other among the stages it invests in.
Where does GROVEPOINT INVESTMENT MANAGEMENT LLP invest?
GROVEPOINT INVESTMENT MANAGEMENT LLP invests in APAC and GB.